Executive Misconduct Leads to Termination at Major Health Plan
The healthcare industry was rocked by scandal when Mark Sanders, CEO of Superior HealthPlan, a Texas-based Centene subsidiary, was terminated for employing private investigators to gather information on lawmakers and customers. The revelation came during Sanders’ testimony before a Texas House Committee hearing, where he admitted to the practice but claimed the company had discontinued using private investigators.
A Centene spokesperson distanced the organization from Sanders’ actions, stating, “The conduct highlighted yesterday during the course of the Texas House Committee hearing is not reflective of our values nor is it a practice Centene’s current leadership condones.” This decisive response underscores the seriousness with which the healthcare industry views ethical breaches, particularly those involving customer privacy and government relations.
Nevada Restructures Medicaid Contract Distribution
In a significant development for Medicaid service providers, Nevada has announced its intent to distribute Medicaid contracts among several major healthcare companies. The state’s notice of intent awards contracts to UnitedHealthcare, Anthem Blue Cross Blue Shield, Centene, CareSource, and Molina Healthcare, with varying levels of service coverage.
UnitedHealthcare received the most limited award, covering only one county, while Centene and CareSource emerged as the top performers based on the state’s scoring system. This redistribution of Medicaid contracts highlights the competitive landscape among healthcare providers seeking government partnerships and the increasing scrutiny states apply when selecting service providers for vulnerable populations.
DOJ Launches Initiative to Combat Anti-Competitive Healthcare Practices
The Department of Justice has established an Anticompetitive Regulations Task Force aimed at eliminating federal and state rules that “undermine free market competition and harm consumers, workers and businesses.” The initiative specifically targets healthcare regulations that “encourage overbilling and consolidation.”
The Antitrust Division will conduct a public inquiry to identify the most significant barriers to competition, with comments due by May 26. Following this consultation period, the task force—comprising attorneys, economists, and other professionals—will determine appropriate actions. This represents a significant step toward addressing systemic issues in healthcare pricing and service delivery.
Blue Cross Blue Shield Plans Report Financial Challenges
Several Blue Cross Blue Shield plans recently disclosed their financial performance for 2024, revealing widespread challenges across the insurance sector:
- Blue Cross Blue Shield of Michigan experienced a substantial loss exceeding $1 billion on revenue. The insurer paid $3 billion more in medical and pharmacy services compared to the previous year, resulting in an underwriting loss of $1.7 billion and an operating margin of -4.2%. GLP-1 weight management drugs contributed significantly to these losses, accounting for more than $1 billion in claims—a 29% increase from 2023. Additionally, the company’s membership decreased by 64,000.
- Regence BlueCross BlueShield of Oregon reported paying $5,757 per member on healthcare in 2024. The plan faced an 8.3% increase in Medicare Advantage claims and recorded an operating loss of 1.2%.
- Regence BlueShield of Idaho added more than 370,000 members but similarly experienced an operating loss of 1.2%. The insurer paid $637 million in healthcare benefits to its members.
- Regence BlueShield in Washington state reported that per-member costs outpaced inflation for its 1.5 million members, with “significant increases” in both prescription drug and medical care expenses.
- Regence BlueCross BlueShield of Utah disclosed a $6,054 per-member cost while growing membership by over 730,000 people. The insurer reported a net income of 1.8% despite an operating loss of 0.4%.
Legal Challenges in the Healthcare Sector
Star Ratings Dispute Leads to Lawsuit
Blue Cross Blue Shield of Massachusetts (BCBSMA) has filed a lawsuit against the Department of Health and Human Services challenging its 2025 star ratings methodology. The insurer claims that the application of a “case-mix adjustment” unfairly reduced its overall star rating from four stars to 3.5 stars, resulting in approximately $35 million in damages.
BCBSMA is requesting that the government recalculate its Consumer Assessment of Healthcare Providers & Systems survey metric without applying the case-mix adjustment, highlighting the financial significance of rating systems in healthcare reimbursement models.
ERISA Lawsuits Challenge Employee Benefit Management
A growing trend of Employee Retirement Income Security Act (ERISA) lawsuits has emerged, with employees of major corporations alleging mismanagement of their benefits, resulting in higher prescription drug costs and PBM overcharges. Recent examples include lawsuits against JPMorgan Chase, Wells Fargo, and Johnson & Johnson.
While the case against Johnson & Johnson was initially dismissed, the plaintiff filed an amended complaint on March 10 that experts believe has a stronger chance of proceeding. Similarly, Wells Fargo successfully had its lawsuit dismissed on March 24, despite the judge acknowledging that the plaintiffs’ frustrations were “understandable.” These cases reflect growing scrutiny of employer benefit management practices.
Industry Innovations and Policy Changes
Caregiving Platform Expands into Medicare Advantage
Cleo, a family caregiving platform, has formed a strategic partnership with Sonder Health Plans, a Medicare Advantage company that recently achieved 500% membership growth in its state. Cleo specializes in chronic condition management and treatment for Alzheimer’s disease and dementia, helping plans improve their star ratings.
CEO Madhavi Vemireddy, M.D., highlighted the personal relevance of this service expansion, stating, “As a member of the ‘sandwich generation,’ I am experiencing first-hand the growing complexity of watching my parents manage their health.” This partnership demonstrates the increasing integration of specialized care management platforms with traditional insurance models.
UnitedHealthcare Reduces Home Health Authorization Requirements
Effective April 1, UnitedHealthcare eliminated prior authorization and other review requirements for home health services under its former naviHealth unit. This change, which applies to Medicare Advantage and dual special needs plans in 37 states, is part of a broader initiative to reduce overall prior authorization volume by 10%, addressing a significant pain point for providers and patients.
Legislative and Policy Developments
Democrats Advocate for ACA Navigator Funding Restoration
A coalition of 22 Democratic lawmakers has urged President Donald Trump to reverse $90 million in cuts to the Affordable Care Act navigator program. These navigators assist individuals in selecting appropriate health plans, though Republicans have historically questioned the program’s cost-effectiveness.
The lawmakers emphasized the critical timing of this issue: “We are especially troubled by the imminent harm of these cuts at a time when navigators are more important than ever. As consumers are confronted with uncertainty around the future of the ACA’s enhanced premium tax credits and are worried about hundreds of billions of dollars of proposed cuts to the Medicaid program, navigators will be essential to helping individuals maintain access to affordable health care coverage.”
Research Insights and Policy Recommendations
Study Highlights Long-term Benefits of Anti-Obesity Medications
Research from the USC Schaeffer Center found that broad coverage of anti-obesity medications (AOMs) could increase life expectancy in the United States by up to 1.8 years and reduce the prevalence of chronic conditions like diabetes. The study suggests these medications could generate positive returns exceeding 13%, even after accounting for treatment costs.
“Although all patients accrue positive net social value from treatment, younger and healthier patients accrue the greatest social returns,” the researchers noted, adding that “expanded access to AOMs could generate $10 trillion in lifetime net social value to those who are currently treatment-eligible.” Despite these potential benefits, only one-third of private insurance plans and nearly all Affordable Care Act plans currently cover these medications.
Analysis Identifies Medicare Advantage Enrollment Challenges
A JAMA Network piece by Weill Cornell Medicine professionals identified two key factors steering beneficiaries toward Medicare Advantage (MA) plans over traditional Medicare: financial incentives for agents and brokers to enroll members in MA plans, which are typically more profitable for insurers, and the comparative difficulty of switching from MA to traditional Medicare.
The authors recommended several reforms, including eliminating extra compensation for MA enrollments, prohibiting enrollment target bonuses and health risk assessments by brokers, improving consumer education about the challenges of switching plans, and implementing state-level requirements for plans to accept all beneficiaries at standardized premium rates.
Paragon Health Institute Reports on Medicaid Challenges
The Trump-aligned Paragon Health Institute released two studies focusing on Medicaid funding issues. One report claims that improper payments by the Centers for Medicare & Medicaid Services (CMS) are significantly higher than officially reported—potentially reaching $1.1 trillion rather than $543 billion—attributing this discrepancy to inadequate eligibility verification and linking these issues to the Affordable Care Act and Medicaid expansion.
A second report examined how providers contribute funds to states that are subsequently used to increase Medicaid spending through federal matching mechanisms, allegedly resulting in excessive federal investment. The institute recommends several policy changes, including block grants, elimination of provider taxes, reduction of the provider tax safe harbor threshold, and restrictions on state-directed payments.
These varied developments across the healthcare landscape illustrate the complex interplay of corporate governance, government regulation, financial pressures, and evolving treatment options that continue to shape the industry.
Discover the latest payers’ news updates with a single click. Follow DistilINFO HealthPlan and stay ahead with updates. Join our community today!
